Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kymera Therapeutics (KYMR) Preferred Dividend Payments (2020)

Historic Preferred Dividend Payments for Kymera Therapeutics (KYMR) over the last 1 years, with Q1 2020 value amounting to $9.0 million.

  • Kymera Therapeutics' Preferred Dividend Payments changed N/A to $9.0 million in Q1 2020 from the same period last year, while for Dec 2020 it was $9.0 million, marking a year-over-year change of. This contributed to the annual value of $9.0 million for FY2020, which is N/A changed from last year.
  • Kymera Therapeutics' Preferred Dividend Payments amounted to $9.0 million in Q1 2020.
  • Kymera Therapeutics' 5-year Preferred Dividend Payments high stood at $9.0 million for Q1 2020, and its period low was $9.0 million during Q1 2020.